Dr. Natraj R Ammakkanavar
Claim this profileCommunity Health Network
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
4 reported clinical trials
8 drugs studied
Area of expertise
1Lung Cancer
Stage IV
KRAS positive
Stage III
2Non-Small Cell Lung Cancer
KRAS positive
PD-L1 positive
PD-L1 negative
Affiliated Hospitals
Clinical Trials Natraj R Ammakkanavar is currently running
LY3537982 + Immunotherapy/Chemotherapy
for Non-Small Cell Lung Cancer
This trial is testing a new drug, LY3537982, combined with standard treatments for patients with advanced lung cancer that have a specific genetic mutation. The goal is to see if this combination works better than the usual treatments alone.
Recruiting1 award Phase 314 criteria
LY3962673
for Pancreatic Cancer
The main purpose of this study is to assess safety \& tolerability and antitumor activity of LY3962673 as monotherapy and in combination with other chemotherapy agents in participants with KRAS G12D-mutant advanced solid tumor types. The study is expected to last approximately 5 years.
Recruiting1 award Phase 14 criteria
More about Natraj R Ammakkanavar
Clinical Trial Related1 year of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Natraj R Ammakkanavar has experience with
- Pembrolizumab
- Carboplatin
- Pemetrexed
- SEA-CD40
- Cisplatin
- LY3537982
Breakdown of trials Natraj R Ammakkanavar has run
Lung Cancer
Non-Small Cell Lung Cancer
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Natraj R Ammakkanavar specialize in?
Natraj R Ammakkanavar focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are KRAS positive.
Is Natraj R Ammakkanavar currently recruiting for clinical trials?
Yes, Natraj R Ammakkanavar is currently recruiting for 2 clinical trials in Indianapolis Indiana. If you're interested in participating, you should apply.
Are there any treatments that Natraj R Ammakkanavar has studied deeply?
Yes, Natraj R Ammakkanavar has studied treatments such as Pembrolizumab, Carboplatin, Pemetrexed.
What is the best way to schedule an appointment with Natraj R Ammakkanavar?
Apply for one of the trials that Natraj R Ammakkanavar is conducting.
What is the office address of Natraj R Ammakkanavar?
The office of Natraj R Ammakkanavar is located at: Community Health Network, Indianapolis, Indiana 46250 United States. This is the address for their practice at the Community Health Network.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.